# Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Phase Treatment in Lupus Nephritis

> **NCT01288664** · PHASE3 · WITHDRAWN · sponsor: **Sun Yat-sen University**

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** ADVAGRAF

## Key facts

- **NCT ID:** NCT01288664
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-01
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** sponsor withdraw from this study
- **Last updated:** 2014-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01288664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01288664, "Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Phase Treatment in Lupus Nephritis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01288664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*